Today: 21 May 2026
Sandisk stock cools in premarket after Nvidia CES spark as BofA lifts target to $390
7 January 2026
1 min read

Sandisk stock cools in premarket after Nvidia CES spark as BofA lifts target to $390

New York, Jan 7, 2026, 07:32 EST — Premarket

  • Sandisk (SNDK) down 0.8% in premarket after closing at a record $349.63
  • Storage and memory stocks rallied on Nvidia’s CES comments on AI infrastructure needs
  • Bank of America raised its Sandisk price target to $390; earnings due Jan 29

Sandisk Corp shares edged down 0.8% to $346.79 in premarket trading on Wednesday, after ending the prior session at a record $349.63. 

The stock’s pullback comes a day after Sandisk closed up 27.6%, its biggest one-day gain in months, in a broad rush into data-storage and memory names. The shares traded between $288.50 and $352.00 on Tuesday, company data showed. 

Investors have been chasing the theme that artificial intelligence will not just lift chip demand but also the plumbing around it — including solid-state drives, or SSDs, which store data using flash memory. Nvidia’s CES keynote included a new storage layer it called “context memory storage,” as it detailed the next generation of chips it said are in full production. Reuters

The rally spilled into peers on Tuesday. Western Digital and Seagate both jumped sharply as traders treated the group as a proxy for AI-related storage demand, according to market commentary. 

Bank of America Securities added fuel early Wednesday, lifting its price target on Sandisk to $390 from $300 and keeping a buy rating, Investing.com reported. 

The backdrop is a market already primed to believe in tighter memory supply. Reuters reported on Monday that investors have been betting on further price gains amid a supply crunch tied to AI infrastructure, while also warning the memory business can swing hard as supply and demand shift. 

Still, the trade is not one-way. Morningstar analyst William Kerwin said Nvidia’s CES messaging likely drove the move, adding that it could mean “more SSD storage to AI infrastructure to improve model speed,” while cautioning that elevated memory pricing can normalize over time. Barron’s

Next up is Sandisk’s own update. The company is scheduled to report fiscal second-quarter results on Jan. 29, with investors watching for guidance on pricing, margins and how much AI-related demand is landing in actual orders. 

Stock Market Today

  • Stocks Climb as Oil Prices and Treasury Yields Drop Ahead of Nvidia Earnings
    May 20, 2026, 6:04 PM EDT. U.S. stocks surged with the Dow Jones up 1.31%, S&P 500 gaining 1.08%, and Nasdaq rising 1.54% on May 20, 2026. This followed a sharp decline in oil prices, with WTI crude down 5.66% at $98.26 per barrel, and Brent crude falling 5.63%. Lower oil prices came after reports of progress in Middle East peace talks. Treasury yields eased, with the 10-year yield dropping over 9 basis points, alleviating recent inflation concerns. Market focus shifts to Nvidia's Q1 earnings report, seen as a critical indicator for the AI sector and chip demand. Nvidia shares rose over 1% ahead of results, trading near a 20% gain for the year. Analysts caution that while expectations are muted, the report could influence the broader market sentiment significantly.

Latest articles

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

20 May 2026
Xanadu Quantum Technologies’ shares surged 20.4% to $14.13 Wednesday, rebounding after a sharp May decline. The company reported Q1 revenue of $2.83 million and a net loss of $20.6 million, with 43.3 million Class B shares outstanding and a prospectus covering up to 293.7 million more. Other quantum stocks also rose. Xanadu is in talks for up to $285 million in Canadian government support.
MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop